2026-01-12
Alzheimer’s disease & alcohol: a toxic duo for the brain?
Addictology
By Ana Espino | Published on January 12, 2026 | 3 min read
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide. Among modifiable risk factors, excessive alcohol consumption has drawn increasing attention. High-dose alcohol exposure is well known for its neurotoxic effects; however, its precise role in the development or worsening of AD remains poorly defined.
Current limitations include a lack of precise mechanistic data, the complexity of interactions between alcohol exposure and brain aging, and the heterogeneity of clinical profiles. The main challenge is to understand how chronic alcohol use disorder promotes Alzheimer’s disease. Several mechanisms have been proposed, including inflammation, oxidative stress, disruption of the blood–brain barrier, and dysregulation of amyloid-β and tau proteins. In this context, the present study was initiated to synthesize current knowledge on the biological and clinical links between alcohol addiction and the risk or progression of Alzheimer’s disease, by examining the underlying mechanisms and potential therapeutic avenues.
This review is based on a narrative analysis of the scientific literature, integrating preclinical data (animal models, cell cultures) and clinical evidence (brain imaging, epidemiological studies). The authors examine neurobiological mechanisms shared by both conditions.
The findings indicate that chronic alcohol exposure acts at multiple levels. It accelerates brain atrophy, increases blood–brain barrier permeability, and promotes neuroinflammation. It also enhances amyloid protein production and aggregation, as well as abnormal tau phosphorylation—two hallmark features of Alzheimer’s disease. Alcohol-related epigenetic modifications may further disrupt the expression of genes involved in neuronal plasticity and cell survival.
Clinically, several epidemiological studies report an increased risk of dementia in individuals with alcohol use disorder, particularly when consumption begins early in life or persists over several decades. Brain MRI studies confirm structural and functional alterations common to both conditions, notably in the hippocampus and prefrontal cortex.
Alzheimer’s disease is a progressive neurodegenerative disorder with a multifactorial origin that potentially includes chronic alcohol consumption. Understanding the mechanisms linking these two conditions is a major challenge for both prevention and the adaptation of therapeutic strategies.
The aim of this review was to explore the biological and clinical connections between chronic alcoholism and the development or worsening of Alzheimer’s disease. It highlights several shared mechanisms, suggesting an aggravating role of alcohol in neurodegeneration.
However, limitations remain and justify further research. Future work should include longitudinal clinical studies, improved stratification of drinking patterns, dose–response analyses, and the evaluation of preventive approaches combining alcohol reduction with neuroprotective strategies.
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide. Among modifiable risk factors, excessive alcohol consumption has drawn increasing attention. High-dose alcohol exposure is well known for its neurotoxic effects; however, its precise role in the development or worsening of AD remains poorly defined.
Current limitations include a lack of precise mechanistic data, the complexity of interactions between alcohol exposure and brain aging, and the heterogeneity of clinical profiles. The main challenge is to understand how chronic alcohol use disorder promotes Alzheimer’s disease. Several mechanisms have been proposed, including inflammation, oxidative stress, disruption of the blood–brain barrier, and dysregulation of amyloid-β and tau proteins. In this context, the present study was initiated to synthesize current knowledge on the biological and clinical links between alcohol addiction and the risk or progression of Alzheimer’s disease, by examining the underlying mechanisms and potential therapeutic avenues.
Does alcohol accelerate neurodegeneration?
This review is based on a narrative analysis of the scientific literature, integrating preclinical data (animal models, cell cultures) and clinical evidence (brain imaging, epidemiological studies). The authors examine neurobiological mechanisms shared by both conditions.
The findings indicate that chronic alcohol exposure acts at multiple levels. It accelerates brain atrophy, increases blood–brain barrier permeability, and promotes neuroinflammation. It also enhances amyloid protein production and aggregation, as well as abnormal tau phosphorylation—two hallmark features of Alzheimer’s disease. Alcohol-related epigenetic modifications may further disrupt the expression of genes involved in neuronal plasticity and cell survival.
Clinically, several epidemiological studies report an increased risk of dementia in individuals with alcohol use disorder, particularly when consumption begins early in life or persists over several decades. Brain MRI studies confirm structural and functional alterations common to both conditions, notably in the hippocampus and prefrontal cortex.
A silent threat that requires better anticipation
Alzheimer’s disease is a progressive neurodegenerative disorder with a multifactorial origin that potentially includes chronic alcohol consumption. Understanding the mechanisms linking these two conditions is a major challenge for both prevention and the adaptation of therapeutic strategies.
The aim of this review was to explore the biological and clinical connections between chronic alcoholism and the development or worsening of Alzheimer’s disease. It highlights several shared mechanisms, suggesting an aggravating role of alcohol in neurodegeneration.
However, limitations remain and justify further research. Future work should include longitudinal clinical studies, improved stratification of drinking patterns, dose–response analyses, and the evaluation of preventive approaches combining alcohol reduction with neuroprotective strategies.
Read next: Cross-addictions: when drugs and alcohol reinforce each other
About the author – Ana Espino
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions through impactful communication.
PhD in Immunology, specialized in Virology
Last press reviews
Colorectal cancer: a blood test to identify patients at risk of recurrence
By Ana Espino | Published on March 2nd, 2026 | 3 min read<br><br>
Cancer: when biotin becomes a therapeutic lever
By Elodie Vaz | Published on February 27, 2026 | 3 min read<br>